Skip to content

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.

Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test as Compared to Standard Testing Technique. Test Performed by a Professional Versus Self-collection and Standard of Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04805892
Enrollment
84
Registered
2021-03-18
Start date
2021-03-17
Completion date
2022-02-23
Last updated
2023-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

This is a research study to evaluate the Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on samples collected by a healthcare professional versus self-collection; and to perform analysis to compare results. In addition, to obtain RT-PCR test results, performed prior to enrollment, and compare all three results.

Interventions

DIAGNOSTIC_TESTBIOZEK COVID-19 Antigen Rapid Test

The BIOZEK COVID-19 Antigen Rapid Test is used for the detection of SARS-CoV-2 antigens in nasopharyngeal swab specimens from individuals who are suspected of having COVID-19.

Sponsors

Mach-E B.V.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects must be ≥18 years of age and have had an RT-PCR test performed prior to enrollment. Subjects must be able to understand and willingly sign a written informed consent. Additionally, participants need to meet at least 1 of the criteria listed below: * Currently experiencing symptoms of COVID-19. * Be clinically diagnosed or suspected to have COVID-19. * Recent past (3 weeks) exhibited symptoms of COVID-19. * Be capable of performing a self-collection of a nasopharyngeal sample with use of nasal swab kit. * Interacted with a COVID-19 positive individual.

Exclusion criteria

Subjects who meet any of the following

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on a Sample Collected by Healthcare Professionals.1 visit, up to 2 hoursThe Biozek Antigen Rapid Tests performed by the trained study personnel on the samples collected by the trained study personnel. Sensitivity was calculated using (TP/TP+FN)\*100% formula. Specificity was calculated using (TN/TN+FP)\*100% formula.

Secondary

MeasureTime frameDescription
Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on Self - Collected Samples.1 visit, up to 2 hoursThe Biozek Antigen Rapid Tests self-performed performed by the subject on the self - collected samples by the subjects. Sensitivity was calculated using (TP/TP+FN)\*100% formula. Specificity was calculated using (TN/TN+FP)\*100% formula.

Countries

United States

Participant flow

Recruitment details

Single site study was performed by Mobile Covid Services, a COVID-19 testing concierge service. Enrollment and testing took place at the subject's home. The Enrollment population consisted of symptomatic and asymptomatic subjects scheduled for an appointment to perform an RT-PCR test for SARS-CoV-2 as the standard of care procedure.

Participants by arm

ArmCount
BIOZEK COVID-19 Antigen Rapid Test
BIOZEK COVID-19 Antigen Rapid Test as compared to standard testing technique. Test performed by a professional versus self-collection and standard of care.
84
Total84

Baseline characteristics

CharacteristicBIOZEK COVID-19 Antigen Rapid Test
Age, Customized
Age 18 - 85 years
84 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
37 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
43 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
22 Participants
Race (NIH/OMB)
More than one race
39 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
Race (NIH/OMB)
White
13 Participants
Region of Enrollment
United States
84 participants
Sex: Female, Male
Female
49 Participants
Sex: Female, Male
Male
35 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 84
other
Total, other adverse events
0 / 84
serious
Total, serious adverse events
0 / 84

Outcome results

Primary

Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on a Sample Collected by Healthcare Professionals.

The Biozek Antigen Rapid Tests performed by the trained study personnel on the samples collected by the trained study personnel. Sensitivity was calculated using (TP/TP+FN)\*100% formula. Specificity was calculated using (TN/TN+FP)\*100% formula.

Time frame: 1 visit, up to 2 hours

Population: One subject was excluded from the analysis due to inconclusive results.

ArmMeasureGroupValue (NUMBER)
BIOZEK COVID-19 Antigen Rapid TestSensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on a Sample Collected by Healthcare Professionals.Sensitivity - Test performed by trained study personnel100 percentage - Sensitivity and specificity
BIOZEK COVID-19 Antigen Rapid TestSensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on a Sample Collected by Healthcare Professionals.Specifity - Test performed by trained study personnel98 percentage - Sensitivity and specificity
Secondary

Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on Self - Collected Samples.

The Biozek Antigen Rapid Tests self-performed performed by the subject on the self - collected samples by the subjects. Sensitivity was calculated using (TP/TP+FN)\*100% formula. Specificity was calculated using (TN/TN+FP)\*100% formula.

Time frame: 1 visit, up to 2 hours

Population: One subject was excluded from the analysis due to inconclusive results.

ArmMeasureGroupValue (NUMBER)
BIOZEK COVID-19 Antigen Rapid TestSensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on Self - Collected Samples.Sensitivity - Test performed by the subject100 percentage - Sensitivity and specificity
BIOZEK COVID-19 Antigen Rapid TestSensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on Self - Collected Samples.Specificity - Test performed by the subject98 percentage - Sensitivity and specificity

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026